25/10/2015 - 20:30
COPENHAGEN – An investigational biologic agent that selectively inhibits the p19 subunit of interleukin-23 was the talk of the 2015 EADV congress based upon its striking outperformance of ustekinumab...
Field of Interest: Dermatology
News Feed: Internal Medicine News - Dermatology